Memorial Sloan Kettering Cancer Center - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 1.2%.

Quarter-by-quarter ownership
Memorial Sloan Kettering Cancer Center ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q1 2022$43,957,000
-58.9%
1,128,255
-57.9%
50.90%
-24.2%
Q4 2021$106,824,000
+10.3%
2,680,6440.0%67.12%
+11.2%
Q3 2021$96,878,000
-11.8%
2,680,6440.0%60.36%
-16.0%
Q2 2021$109,880,000
-6.0%
2,680,6440.0%71.84%
-0.3%
Q1 2021$116,930,000
-34.5%
2,680,644
-24.8%
72.07%
-4.6%
Q4 2020$178,473,0003,565,88775.56%
Other shareholders
ROYALTY PHARMA PLC shareholders Q3 2021
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders